Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Greg K. Behbehani"'
Autor:
Katherine E. Miller, Bryon D. Johnson, Stephan Kadauke, Yongping Wang, Nancy Bunin, Jordan Milner, Elaine R. Mardis, Dean A. Lee, Elena Maryamchik, Lauren Harrison, Margaret G. Lamb, Julie-An Talano, Elana Y. Rosenthal, Lakshmi Prakruthi Rao Venkata, Yaya Chu, Mitchell S. Cairo, Greg K. Behbehani, Rosemarie Shaw, Hsiaochi Chang, Olivia Rigot, Janet Ayello
Publikováno v:
Blood
Background: The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pandemic that has taken millions of lives around the globe. Treatment of patients with moderate and severe COVID-19 di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e5f424661b2f49a6a7f1aed09877755
http://europepmc.org/articles/PMC8701584
http://europepmc.org/articles/PMC8701584
Autor:
Ying Huang, Meixiao Long, Karilyn Larkin, Uma Borate, James S. Blachly, Tamanna Haque, Ramiro Garzon, Sarah A Wall, Melanie T Rebechi, Kieran D Sahasrabudhe, Sumithira Vasu, Alison Walker, Alice S. Mims, Greg K. Behbehani, Bradley W. Blaser, Bhavana Bhatnagar, Ayman Saad
Publikováno v:
Blood. 138:4125-4125
Introduction The FDA has recently approved several oral targeted therapies for Acute Myeloid Leukemia (AML). These therapies have been approved in patients with relapsed/refractory disease and as frontline therapy in patients ineligible for intensive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3031ff5298575d3720646769beb1047
https://doi.org/10.1182/blood-2021-148676
https://doi.org/10.1182/blood-2021-148676
Autor:
Sarah A Wall, Marcos de Lima, Alison Walker, James S. Blachly, Hannah Choe, Aarohi Thakkar, Sumithira Vasu, Ella Troy, Nicole Szuminski, Greg K. Behbehani, Nidhi Sharma, Lynn O'Donnell, Dean A. Lee, Robin J Nakkula
Publikováno v:
Blood. 138:1732-1732
Background: Natural Killer (NK) cells are cytotoxic lymphocytes that are able to exert an anti-tumor effect in an MHC-I independent manner, but are dysfunctional and reduced in number in patients with leukemia. Several studies have shown therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::839550d2ed48fc24f67289fb4cdc20f8
https://doi.org/10.1182/blood-2021-150750
https://doi.org/10.1182/blood-2021-150750